Simvastatin
Product Images NDC 71610-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 71610-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0076 30)

Bottle Label 10 mg (71610 0076 30)
Simvastatin 10 mg tablet label showing a package of 30 tablets. The label displays the proprietary name Simvastatin with strength of 10 mg, mentions the tablet count of 30, and includes storage instructions. The manufacturer is Aurabindo Pharma Limited, Mahaboob Nagar, India, with repackaging by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. The label also states the product is RX only.*
FDA Label Image

Bottle Label 40 mg (71610 0077 15)

Bottle Label 40 mg (71610 0077 15)
Simvastatin 40 mg tablet blister card containing 15 tablets. The label includes the drug name Simvastatin with strength 40 mg, the quantity of 15 tablets, and repackaging information by Aphena Pharma Solutions - Tennessee, LLC. Storage instructions and manufacturer details (Aurobindo Pharma Limited, India) are also visible. The label displays barcodes and RX Only designation.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin Fig1)

Figure 1 The Effects Of Treatment With Simvastatin On Major Vascular Events And Major Coronary Events In Hps (Simvastatin Fig1)
A data table presenting major vascular and coronary events with incidence percentages for Simvastatin versus placebo across several baseline characteristics, including CHD status, diabetes, peripheral vascular disease, cerebrovascular disease, gender, age groups, LDL-cholesterol, and HDL-cholesterol levels. The table includes risk ratio plots with 95% confidence intervals comparing Simvastatin to placebo for each subgroup.*
FDA Label Image

Chemical Structure (Simvastatin Str)

Chemical Structure (Simvastatin Str)
Chemical structure of simvastatin, showing its molecular framework including cyclic rings, hydroxyl, and carbonyl functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.